Abstract Title:

Resveratrol bioavailability and toxicity in humans.

Abstract Source:

Mol Nutr Food Res. 2010 Jan;54(1):7-16. PMID: 20013887

Abstract Author(s):

Charles-Henry Cottart, Valérie Nivet-Antoine, Christelle Laguillier-Morizot, Jean-Louis Beaudeux

Article Affiliation:

APHP, Hôpital Universitaire Charles Foix, Service de Biochimie, Ivry sur Seine, France. [email protected]

Abstract:

Numerous data are now available on the beneficial properties of the polyphenolic compound resveratrol including its anti-inflammatory and antitumor effects. However, few studies have been performed with resveratrol in humans, and the results of these studies appear fragmentary and sometimes contradictory due to variations in conditions of administration, protocols and methods of assessment. This review article presents the results of recent studies investigating the pharmacokinetics, bioavailability, and toxicity of resveratrol in humans. Resveratrol is well absorbed, rapidly metabolized, mainly into sulfo and glucuronides conjugates which are eliminated in urine. Resveratrol seems to be well tolerated and no marked toxicity was reported. These data are important in the context of human efficacy studies, and they provide further support for the use of resveratrol as a pharmacological drug in human medicine.

Study Type : Review

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.